Cargando…
BCG vaccination induced protection from COVID-19
There are worldwide urgency, efforts, and uncertainties for the discovery of a vaccine against SARS CoV2. If successful, it will take its own time till useful for the humans. Till the specific vaccine is available, there are evidences for repurposing existing other vaccines. It is observed that coun...
Autores principales: | Mohapatra, Prasanta Raghab, Mishra, Baijayantimala, Behera, Bijayini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tuberculosis Association of India. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413058/ https://www.ncbi.nlm.nih.gov/pubmed/33641831 http://dx.doi.org/10.1016/j.ijtb.2020.08.004 |
Ejemplares similares
-
BCG Vaccination Policy and Protection Against COVID-19: Correspondence
por: Mohapatra, Prasanta Raghab, et al.
Publicado: (2020) -
Letter in Response to “Melioidosis in a Tertiary Care Center from South India: A 5-year Experience
por: Behera, Bijayini, et al.
Publicado: (2023) -
Regulatory approval of COVID-19 vaccine for restricted use in clinical trial mode
por: Mohapatra, Prasanta Raghab, et al.
Publicado: (2021) -
Laboratory Investigations in Patients with Community Acquired Sepsis and/or Pneumonia Caused by Burkholderia pseudomallei
por: Behera, Bijayini, et al.
Publicado: (2022) -
Study of respiratory viruses and their coinfection with bacterial and fungal pathogens in acute exacerbation of chronic obstructive pulmonary diseases
por: Jahan, Rahat, et al.
Publicado: (2021)